Fundraising September 15, 2024 – October 1, 2024 About fundraising

P540 GB004, a novel prolyl hydroxylase inhibitor for...

P540 GB004, a novel prolyl hydroxylase inhibitor for inflammatory bowel disease, leads to gut-targeted HIF-1α pathway engagement in a multiple-dose study in healthy subjects

Levesque, B, Taylor Meadows, K, Buch, A, Flynn, M, Peters, K, Olson, A, Shen, J, Slee, D, Van Biene, C, Aranda, R, Vande Casteele, N, Opiteck, G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.668
Date:
January, 2020
File:
PDF, 1.28 MB
english, 2020
Conversion to is in progress
Conversion to is failed